Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 8(11): e80081, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24244615

RESUMO

Although surveillance efforts that monitor the emergence of drug-resistant strains of influenza are critical, systematic analysis is overlooked in most developing countries. We report on the occurrence of strains of pandemic influenza A(H1N1)pdm09 with resistance and decreased susceptibility to oseltamivir (OST) in Brazil in 2009, 2011 and 2012. We found 7 mutant viruses, 2 with the mutation S247N and other 5 with the mutation H275Y. Most of these viruses were from samples concentrated in the southern region of Brazil. Some of these resistant viruses were detected prior to the initiation of OST treatment, suggesting that community transmission of mutant viruses may exist. Moreover, we show that one of these OST-resistant (H275Y) strains of A(H1N1)pdm09 was discovered in the tri-border region between Brazil, Argentina and Paraguay, highlighting that this strain could also be found in other Latin American countries. Our findings reinforce the importance of enhanced antiviral resistance surveillance in Brazil and in other Latin American countries to confirm or rule out the community transmission of OST-resistant strains of A(H1N1)pdm09.


Assuntos
Farmacorresistência Viral/genética , Vírus da Influenza A Subtipo H1N1/genética , Influenza Humana/transmissão , Neuraminidase/genética , Proteínas Virais/genética , Adolescente , Adulto , Idoso , Animais , Antivirais/uso terapêutico , Brasil/epidemiologia , Criança , Pré-Escolar , Cães , Farmacorresistência Viral/efeitos dos fármacos , Monitoramento Epidemiológico , Humanos , Lactente , Recém-Nascido , Vírus da Influenza A Subtipo H1N1/isolamento & purificação , Influenza Humana/tratamento farmacológico , Influenza Humana/epidemiologia , Influenza Humana/virologia , Células Madin Darby de Rim Canino , Pessoa de Meia-Idade , Mutação , Neuraminidase/antagonistas & inibidores , Oseltamivir/uso terapêutico , Proteínas Virais/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...